Extraordinary Response of Metastatic Pancreatic Cancer to Chemotherapy / 대한소화기암학회지
Journal of Digestive Cancer Report
; (2): 22-25, 2019.
Article
in Ko
| WPRIM
| ID: wpr-787283
Responsible library:
WPRO
ABSTRACT
A 58-year-old woman presented with right flank and back pain for one month. After undergoing an abdominal computed tomography (CT), she was referred to our hospital. The abdominal CT showed a hypodense pancreatic tail mass with multiple retroperitoneal lymph node metastases. Positron emission tomography-computed tomography (PET-CT) scan showed high 18F-FDG uptake in pancreatic tumor and enlarged lymph nodes. Endoscopic ultrasound fine needle aspiration (EUS-FNA) revealed adenocarcinoma, which stained strongly in hENT1 (human equilibrative nucleoside transporter 1) on immunohistochemistry. She received gemcitabine 1,000 mg/m² + nanoparticle albumin-bound paclitaxel 125 mg/m² as a palliative chemotherapy. Follow-up abdominal CT and PET-CT after 4 cycles of chemotherapy showed that both pancreatic mass and the metastatic retroperitoneal lymph nodes were nearly disappeared. We report a case of 58-year-old female with metastatic pancreatic cancer who had a dramatic response to palliative chemotherapy (gemcitabine plus nanoparticle albumin-bound paclitaxel).
Key words
Full text:
1
Index:
WPRIM
Main subject:
Pancreatic Neoplasms
/
Tail
/
Immunohistochemistry
/
Adenocarcinoma
/
Tomography, X-Ray Computed
/
Follow-Up Studies
/
Ultrasonography
/
Back Pain
/
Fluorodeoxyglucose F18
/
Nucleoside Transport Proteins
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Limits:
Female
/
Humans
Language:
Ko
Journal:
Journal of Digestive Cancer Report
Year:
2019
Type:
Article